503 related articles for article (PubMed ID: 19046218)
1. Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects.
Abdul-Ghani MA; Matsuda M; DeFronzo RA
Diabet Med; 2008 Nov; 25(11):1289-94. PubMed ID: 19046218
[TBL] [Abstract][Full Text] [Related]
2. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test.
Abdul-Ghani MA; Matsuda M; Balas B; DeFronzo RA
Diabetes Care; 2007 Jan; 30(1):89-94. PubMed ID: 17192339
[TBL] [Abstract][Full Text] [Related]
3. Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range.
Jani R; Molina M; Matsuda M; Balas B; Chavez A; DeFronzo RA; Abdul-Ghani M
Diabetes Care; 2008 Feb; 31(2):311-5. PubMed ID: 18000182
[TBL] [Abstract][Full Text] [Related]
4. Contribution of skeletal muscle mass on sex differences in 2-hour plasma glucose levels after oral glucose load in Thai subjects with normal glucose tolerance.
Rattarasarn C; Leelawattana R; Soonthornpun S
Metabolism; 2010 Feb; 59(2):172-6. PubMed ID: 19765781
[TBL] [Abstract][Full Text] [Related]
5. Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database.
Sesti G; Andreozzi F; Bonadonna RC; De Mattia G; Leonetti F; Luzi L; Marini MA; Natali A; Vettor R; Bonora E;
Diabetes Metab Res Rev; 2008 Feb; 24(2):130-6. PubMed ID: 17922529
[TBL] [Abstract][Full Text] [Related]
6. Elevated fasting insulin concentrations associate with impaired insulin signaling in skeletal muscle of healthy subjects independent of obesity.
Korsheninnikova E; Seppälä-Lindroos A; Vehkavaara S; Goto T; Virkamäki A
Diabetes Metab Res Rev; 2002; 18(3):209-16. PubMed ID: 12112939
[TBL] [Abstract][Full Text] [Related]
7. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
[TBL] [Abstract][Full Text] [Related]
8. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle magnesium content in identical twins, discordant for type 2 diabetes.
Djurhuus MS; Vaag A; Altura BM; Altura BT; Klitgaard NA
Diabetes Metab; 2002 Jun; 28(3):201-7. PubMed ID: 12149600
[TBL] [Abstract][Full Text] [Related]
10. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
11. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
Bock G; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Chandramouli V; Landau BR; Rizza RA
Diabetes; 2007 Jun; 56(6):1703-11. PubMed ID: 17384334
[TBL] [Abstract][Full Text] [Related]
12. Metabolic characteristics of soleus muscle in relation to insulin action in the offspring of hypertensive parents.
Kratochvílová S; Vyhnanovská P; Vlasáková Z; Hájek M; Skibová J; Pelikánová T
Metabolism; 2006 Oct; 55(10):1388-96. PubMed ID: 16979411
[TBL] [Abstract][Full Text] [Related]
13. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.
Anderwald C; Anderwald-Stadler M; Promintzer M; Prager G; Mandl M; Nowotny P; Bischof MG; Wolzt M; Ludvik B; Kästenbauer T; Pacini G; Luger A; Krebs M
Diabetes Care; 2007 Sep; 30(9):2374-80. PubMed ID: 17595351
[TBL] [Abstract][Full Text] [Related]
14. Comparison of several insulin sensitivity indices derived from basal plasma insulin and glucose levels with minimal model indices.
García-Estévez DA; Araújo-Vilar D; Fiestras-Janeiro G; Saavedra-González A; Cabezas-Cerrato J
Horm Metab Res; 2003 Jan; 35(1):13-7. PubMed ID: 12669265
[TBL] [Abstract][Full Text] [Related]
15. Pre-clinical methods for the determination of insulin sensitivity.
Zsuga J; Tory K; Jaszlits L; Bajza A; Nemeth J; Peitl B; Szilvassy Z
J Biochem Biophys Methods; 2004 Oct; 61(1-2):253-8. PubMed ID: 15560942
[TBL] [Abstract][Full Text] [Related]
16. A study to evaluate surrogate markers of insulin resistance in forty euglycemic healthy subjects.
Gupta AK; Jain SK
J Assoc Physicians India; 2004 Jul; 52():549-53. PubMed ID: 15645980
[TBL] [Abstract][Full Text] [Related]
17. [Hepatic and peripheral insulin resistance as a cause of hyperglycemia in non-insulin-dependent (type 2) diabetes mellitus: a review].
Bratusch-Marrain P; Waldhäusl W
Wien Klin Wochenschr; 1987 Apr; 99(7):211-6. PubMed ID: 3296467
[TBL] [Abstract][Full Text] [Related]
18. Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers.
Nicod N; Giusti V; Besse C; Tappy L
Obes Res; 2003 May; 11(5):625-31. PubMed ID: 12740452
[TBL] [Abstract][Full Text] [Related]
19. Elevated fasting plasma C-peptide occurs in non-diabetic individuals with fatty liver, irrespective of insulin resistance.
Perseghin G; Caumo A; Lattuada G; De Cobelli F; Ntali G; Esposito A; Belloni E; Canu T; Ragogna F; Scifo P; Del Maschio A; Luzi L
Diabet Med; 2009 Sep; 26(9):847-54. PubMed ID: 19719704
[TBL] [Abstract][Full Text] [Related]
20. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
